Pimecrolimus is an immunomodulating agent used in the treatment of atopic dermatitis (eczema). It is available as a topical cream once marketed by Novartis (however Galderma has been promoting the compound in Canada since early 2007) under the trade name Elidel.
This page contains content from the copyrighted Wikipedia article "Pimecrolimus"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
